IL102088A0 - Me20:monoclonal antibodies and antigen for human melanoma - Google Patents

Me20:monoclonal antibodies and antigen for human melanoma

Info

Publication number
IL102088A0
IL102088A0 IL102088A IL10208892A IL102088A0 IL 102088 A0 IL102088 A0 IL 102088A0 IL 102088 A IL102088 A IL 102088A IL 10208892 A IL10208892 A IL 10208892A IL 102088 A0 IL102088 A0 IL 102088A0
Authority
IL
Israel
Prior art keywords
antigen
monoclonal antibodies
human melanoma
melanoma
human
Prior art date
Application number
IL102088A
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL102088A0 publication Critical patent/IL102088A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL102088A 1991-06-05 1992-06-03 Me20:monoclonal antibodies and antigen for human melanoma IL102088A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71061391A 1991-06-05 1991-06-05

Publications (1)

Publication Number Publication Date
IL102088A0 true IL102088A0 (en) 1993-01-14

Family

ID=24854790

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102088A IL102088A0 (en) 1991-06-05 1992-06-03 Me20:monoclonal antibodies and antigen for human melanoma

Country Status (7)

Country Link
AU (1) AU2170692A (en)
IE (1) IE921810A1 (en)
IL (1) IL102088A0 (en)
MX (1) MX9202642A (en)
PT (1) PT100568A (en)
WO (1) WO1992021767A1 (en)
ZA (1) ZA924068B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0756604A1 (en) 1994-04-22 1997-02-05 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Melanoma antigens
US5874560A (en) * 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
AT502292B1 (en) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology MELANOMA DIAGNOSIS
WO2010030325A1 (en) * 2008-09-09 2010-03-18 Albert Einstein College Of Medicine Of Yeshiva University Methods for increasing efficacy of radioimmunotherapy of melanoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339798C (en) * 1985-02-01 1998-04-07 Alan N. Houghton Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans
GB2188637B (en) * 1986-02-07 1990-11-14 Oncogen Vaccines against melanoma

Also Published As

Publication number Publication date
AU2170692A (en) 1993-01-08
PT100568A (en) 1993-09-30
ZA924068B (en) 1993-02-24
MX9202642A (en) 1992-12-01
WO1992021767A1 (en) 1992-12-10
IE921810A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
ZA957634B (en) Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
HU9601574D0 (en) Humanized antibodies and uses thereof
IL108199A0 (en) Monoclonal antibodies against the human il-4 receptor and hybridomas producing the same
HUT66753A (en) Novel antibodies and methods for their use
IL104620A (en) Humanized monoclonal antibodies against human interleukin-5
ZA949227B (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodes
EP0603735A3 (en) Monoclonal antibodies that define a unique antigen of human b-cell antigen receptor complex.
IL89489A0 (en) Chimeric antibodies directed against human carcinoembryonic antigen
ZA9510806B (en) Anti-xv-integrin monoclonal antibody
EP0580859A4 (en) Anti-eda monoclonal antibody
GB8910395D0 (en) Human monoclonal antibody and hybridoma producing the same
IL100869A0 (en) Monoclonal ige receptor antibodies
EP0506523A3 (en) Monoclonal antibodies
EP0977590A4 (en) Human monoclonal antibodies
IL102088A0 (en) Me20:monoclonal antibodies and antigen for human melanoma
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
EP0508282A3 (en) Anti-idiotypic monoclonal antibodies
GB9014652D0 (en) Antigen
ZA912136B (en) Anti-oncostatin m monoclonal antibodies
GB9118013D0 (en) Monoclonal antibodies and their use
EP0546634A3 (en) Tumor associated monoclonal antibody 88bv59
AU5852094A (en) Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
IL104291A0 (en) Antigenic epitopes and antibodies against them
GB9204514D0 (en) Monoclonal antibodies and their use
GB9210944D0 (en) Monoclonal antibodies and their use